PD-L1/PD-1 presence in the tumor microenvironment and activity of PD-1 blockade in multiple myeloma

Leukemia. 2015 Oct;29(10):2110-3. doi: 10.1038/leu.2015.79. Epub 2015 Mar 17.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • B7-H1 Antigen / metabolism*
  • Bone Marrow / metabolism*
  • Case-Control Studies
  • Cells, Cultured
  • Female
  • Follow-Up Studies
  • Humans
  • Immunophenotyping
  • Killer Cells, Natural / metabolism
  • Killer Cells, Natural / pathology
  • Mice
  • Mice, Inbred C57BL
  • Multiple Myeloma / metabolism
  • Multiple Myeloma / mortality
  • Multiple Myeloma / pathology*
  • Neoplasm Recurrence, Local / metabolism
  • Neoplasm Recurrence, Local / mortality
  • Neoplasm Recurrence, Local / pathology*
  • Neoplasm Staging
  • Neoplasm, Residual / metabolism
  • Neoplasm, Residual / mortality
  • Neoplasm, Residual / pathology*
  • Prognosis
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Programmed Cell Death 1 Receptor / metabolism
  • Prospective Studies
  • Stem Cells / metabolism
  • Stem Cells / pathology
  • Survival Rate
  • T-Lymphocytes / metabolism
  • T-Lymphocytes / pathology
  • Tumor Microenvironment*

Substances

  • B7-H1 Antigen
  • PDCD1 protein, human
  • Programmed Cell Death 1 Receptor